Which has better earnings & valuation, AMZN or TDOC?

Amazon.com has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Amazon.com, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Amazon.com $716.92B 3.75 $77.67B $12.43 20.05 Teladoc Health $2.49B 0.45 -$200.32M -$0.99 N/A

Does the media favor AMZN or TDOC?

In the previous week, Amazon.com had 407 more articles in the media than Teladoc Health. MarketBeat recorded 416 mentions for Amazon.com and 9 mentions for Teladoc Health. Amazon.com's average media sentiment score of 1.02 beat Teladoc Health's score of -0.01 indicating that Amazon.com is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amazon.com 283 Very Positive mention(s) 63 Positive mention(s) 28 Neutral mention(s) 32 Negative mention(s) 9 Very Negative mention(s) Positive Teladoc Health 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to TDOC or CRSP?

In the previous week, CRISPR Therapeutics had 6 more articles in the media than Teladoc Health. MarketBeat recorded 15 mentions for CRISPR Therapeutics and 9 mentions for Teladoc Health. CRISPR Therapeutics' average media sentiment score of 0.57 beat Teladoc Health's score of -0.01 indicating that CRISPR Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral CRISPR Therapeutics 6 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, TDOC or ROKU?

Roku has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Roku, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teladoc Health $2.49B 0.45 -$200.32M -$0.99 N/A Roku $4.74B 4.81 $88.36M $2.34 65.59

Is TDOC or ROKU more profitable?

Roku has a net margin of 6.82% compared to Teladoc Health's net margin of -7.13%. Roku's return on equity of 13.73% beat Teladoc Health's return on equity. Company Net Margins Return on Equity Return on Assets Teladoc Health -7.13% -12.15% -5.83% Roku 6.82% 13.73% 8.34%

Does the media prefer TDOC or ROKU?

In the previous week, Roku had 4 more articles in the media than Teladoc Health. MarketBeat recorded 13 mentions for Roku and 9 mentions for Teladoc Health. Roku's average media sentiment score of 0.45 beat Teladoc Health's score of -0.01 indicating that Roku is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Roku 4 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media prefer ZM or TDOC?

In the previous week, Teladoc Health had 2 more articles in the media than Zoom Communications. MarketBeat recorded 9 mentions for Teladoc Health and 7 mentions for Zoom Communications. Zoom Communications' average media sentiment score of 0.70 beat Teladoc Health's score of -0.01 indicating that Zoom Communications is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zoom Communications 4 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teladoc Health 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media prefer AMWL or TDOC?

In the previous week, Teladoc Health had 8 more articles in the media than American Well. MarketBeat recorded 9 mentions for Teladoc Health and 1 mentions for American Well. American Well's average media sentiment score of 0.59 beat Teladoc Health's score of -0.01 indicating that American Well is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment American Well 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teladoc Health 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Teladoc Health (TDOC) Competitors

$6.13 -0.22 (-3.46%)

Closing price 09/23/2026 03:59 PM Eastern

Extended Trading

$6.16 +0.03 (+0.49%)

As of 09/23/2026 07:43 PM Eastern

Compare

TDOC vs. AMZN, CRSP, ROKU, ZM, and AMWL

Should you buy Teladoc Health stock or one of its competitors? Teladoc Health's main competitors and comparable companies include Amazon.com (AMZN), CRISPR Therapeutics (CRSP), Roku (ROKU), Zoom Communications (ZM), and American Well (AMWL). Companies are selected based on similarities in market, industry, and size.

How does Teladoc Health compare to Amazon.com?

Amazon.com (NASDAQ:AMZN) and Teladoc Health (NYSE:TDOC) are related companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

Amazon.com has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Amazon.com, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amazon.com	$716.92B	3.75	$77.67B	$12.43	20.05
Teladoc Health	$2.49B	0.45	-$200.32M	-$0.99	N/A

Amazon.com has a beta of 1.44, suggesting that its share price is 44% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.12, suggesting that its share price is 112% more volatile than the broader market.

Amazon.com currently has a consensus price target of $321.19, indicating a potential upside of 28.85%. Teladoc Health has a consensus price target of $7.54, indicating a potential upside of 22.93%. Given Amazon.com's stronger consensus rating and higher possible upside, equities research analysts clearly believe Amazon.com is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amazon.com	0 Sell rating(s)	3 Hold rating(s)	56 Buy rating(s)	0 Strong Buy rating(s)	2.95
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

72.2% of Amazon.com shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 8.9% of Amazon.com shares are owned by insiders. Comparatively, 0.7% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Amazon.com has a net margin of 17.44% compared to Teladoc Health's net margin of -7.13%. Amazon.com's return on equity of 18.00% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amazon.com	17.44%	18.00%	8.97%
Teladoc Health	-7.13%	-12.15%	-5.83%

In the previous week, Amazon.com had 407 more articles in the media than Teladoc Health. MarketBeat recorded 416 mentions for Amazon.com and 9 mentions for Teladoc Health. Amazon.com's average media sentiment score of 1.02 beat Teladoc Health's score of -0.01 indicating that Amazon.com is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amazon.com	283 Very Positive mention(s)	63 Positive mention(s)	28 Neutral mention(s)	32 Negative mention(s)	9 Very Negative mention(s)	Positive
Teladoc Health	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Amazon.com beats Teladoc Health on 14 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to CRISPR Therapeutics?

Teladoc Health (NYSE:TDOC) and CRISPR Therapeutics (NASDAQ:CRSP) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

Teladoc Health has a net margin of -7.13% compared to CRISPR Therapeutics' net margin of -3,368.72%. Teladoc Health's return on equity of -12.15% beat CRISPR Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-7.13%	-12.15%	-5.83%
CRISPR Therapeutics	-3,368.72%	-24.39%	-18.25%

In the previous week, CRISPR Therapeutics had 6 more articles in the media than Teladoc Health. MarketBeat recorded 15 mentions for CRISPR Therapeutics and 9 mentions for Teladoc Health. CRISPR Therapeutics' average media sentiment score of 0.57 beat Teladoc Health's score of -0.01 indicating that CRISPR Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
CRISPR Therapeutics	6 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Teladoc Health has a beta of 2.12, indicating that its share price is 112% more volatile than the broader market. Comparatively, CRISPR Therapeutics has a beta of 1.76, indicating that its share price is 76% more volatile than the broader market.

Teladoc Health has higher revenue and earnings than CRISPR Therapeutics. CRISPR Therapeutics is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.49B	0.45	-$200.32M	-$0.99	N/A
CRISPR Therapeutics	$3.51M	1,536.02	-$581.60M	-$4.76	N/A

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 69.2% of CRISPR Therapeutics shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by insiders. Comparatively, 5.2% of CRISPR Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Teladoc Health presently has a consensus target price of $7.54, indicating a potential upside of 22.93%. CRISPR Therapeutics has a consensus target price of $67.94, indicating a potential upside of 21.85%. Given Teladoc Health's higher possible upside, analysts plainly believe Teladoc Health is more favorable than CRISPR Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25
CRISPR Therapeutics	1 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.59

Summary

Teladoc Health beats CRISPR Therapeutics on 10 of the 17 factors compared between the two stocks.

How does Teladoc Health compare to Roku?

Teladoc Health (NYSE:TDOC) and Roku (NASDAQ:ROKU) are related companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

Teladoc Health currently has a consensus target price of $7.54, suggesting a potential upside of 22.93%. Roku has a consensus target price of $156.17, suggesting a potential upside of 1.74%. Given Teladoc Health's higher possible upside, equities research analysts clearly believe Teladoc Health is more favorable than Roku.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25
Roku	0 Sell rating(s)	19 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.33

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 86.3% of Roku shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by company insiders. Comparatively, 13.5% of Roku shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Teladoc Health has a beta of 2.12, indicating that its share price is 112% more volatile than the broader market. Comparatively, Roku has a beta of 2.05, indicating that its share price is 105% more volatile than the broader market.

Roku has a net margin of 6.82% compared to Teladoc Health's net margin of -7.13%. Roku's return on equity of 13.73% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-7.13%	-12.15%	-5.83%
Roku	6.82%	13.73%	8.34%

In the previous week, Roku had 4 more articles in the media than Teladoc Health. MarketBeat recorded 13 mentions for Roku and 9 mentions for Teladoc Health. Roku's average media sentiment score of 0.45 beat Teladoc Health's score of -0.01 indicating that Roku is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Roku	4 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Roku has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Roku, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.49B	0.45	-$200.32M	-$0.99	N/A
Roku	$4.74B	4.81	$88.36M	$2.34	65.59

Summary

Roku beats Teladoc Health on 15 of the 17 factors compared between the two stocks.

How does Teladoc Health compare to Zoom Communications?

Zoom Communications (NASDAQ:ZM) and Teladoc Health (NYSE:TDOC) are related companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

In the previous week, Teladoc Health had 2 more articles in the media than Zoom Communications. MarketBeat recorded 9 mentions for Teladoc Health and 7 mentions for Zoom Communications. Zoom Communications' average media sentiment score of 0.70 beat Teladoc Health's score of -0.01 indicating that Zoom Communications is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zoom Communications	4 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teladoc Health	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Zoom Communications has a net margin of 65.19% compared to Teladoc Health's net margin of -7.13%. Zoom Communications' return on equity of 10.86% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zoom Communications	65.19%	10.86%	8.93%
Teladoc Health	-7.13%	-12.15%	-5.83%

Zoom Communications presently has a consensus price target of $113.62, suggesting a potential upside of 23.63%. Teladoc Health has a consensus price target of $7.54, suggesting a potential upside of 22.93%. Given Zoom Communications' stronger consensus rating and higher possible upside, research analysts clearly believe Zoom Communications is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zoom Communications	0 Sell rating(s)	11 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.58
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

66.5% of Zoom Communications shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 8.8% of Zoom Communications shares are owned by insiders. Comparatively, 0.7% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Zoom Communications has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Zoom Communications, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zoom Communications	$4.99B	5.37	$1.90B	$10.80	8.51
Teladoc Health	$2.49B	0.45	-$200.32M	-$0.99	N/A

Zoom Communications has a beta of 1.04, suggesting that its stock price is 4% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.12, suggesting that its stock price is 112% more volatile than the broader market.

Summary

Zoom Communications beats Teladoc Health on 13 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to American Well?

American Well (NYSE:AMWL) and Teladoc Health (NYSE:TDOC) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.

In the previous week, Teladoc Health had 8 more articles in the media than American Well. MarketBeat recorded 9 mentions for Teladoc Health and 1 mentions for American Well. American Well's average media sentiment score of 0.59 beat Teladoc Health's score of -0.01 indicating that American Well is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Well	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teladoc Health	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

American Well has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$218.53M	1.00	-$95.70M	-$4.77	N/A
Teladoc Health	$2.49B	0.45	-$200.32M	-$0.99	N/A

Teladoc Health has a net margin of -7.13% compared to American Well's net margin of -35.75%. Teladoc Health's return on equity of -12.15% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
Teladoc Health	-7.13%	-12.15%	-5.83%

American Well has a beta of 1.71, suggesting that its share price is 71% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.12, suggesting that its share price is 112% more volatile than the broader market.

American Well presently has a consensus price target of $9.50, suggesting a potential downside of 27.80%. Teladoc Health has a consensus price target of $7.54, suggesting a potential upside of 22.93%. Given Teladoc Health's stronger consensus rating and higher probable upside, analysts plainly believe Teladoc Health is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

56.0% of American Well shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 12.8% of American Well shares are owned by insiders. Comparatively, 0.7% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Teladoc Health beats American Well on 11 of the 16 factors compared between the two stocks.

Get Teladoc Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TDOC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TDOC vs. The Competition

Export

Metric	Teladoc Health	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.15B	$1.72B	$7.31B	$23.09B
Dividend Yield	N/A	3.89%	2.52%	3.61%
P/E Ratio	-6.19	20.86	274.02	28.10
Price / Sales	0.45	89.26	633.28	20.16
Price / Cash	3.53	31.72	77.80	38.68
Price / Book	0.78	6.20	10.44	4.66
Net Income	-$200.32M	-$18.66M	$3.49B	$1.07B
7 Day Performance	-2.78%	-0.33%	-0.66%	-1.27%
1 Month Performance	-1.05%	1.85%	-3.16%	-4.71%
1 Year Performance	-27.24%	-17.31%	15.15%	7.48%

Teladoc Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TDOC Teladoc Health	2.8024 of 5 stars	$6.13 -3.5%	$7.54 +22.9%	-26.9%	$1.15B	$2.49B	N/A	5,600
AMZN Amazon.com	4.9595 of 5 stars	$253.54 -1.3%	$323.26 +27.5%	+12.9%	$2.73T	$716.92B	20.40	1,576,000	Trending News Analyst Revision
CRSP CRISPR Therapeutics	2.5422 of 5 stars	$52.96 +2.4%	$68.06 +28.5%	-8.2%	$5.12B	$11M	N/A	393	Insider Trade
ROKU Roku	2.9972 of 5 stars	$157.45 +1.6%	$156.17 -0.8%	+55.0%	$23.37B	$5.21B	67.29	3,600
ZM Zoom Communications	4.403 of 5 stars	$95.36 -0.2%	$112.55 +18.0%	+11.3%	$27.89B	$4.99B	8.83	7,438

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TDOC) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Teladoc Health (TDOC) Competitors

TDOC vs. AMZN, CRSP, ROKU, ZM, and AMWL

How does Teladoc Health compare to Amazon.com?

Summary

How does Teladoc Health compare to CRISPR Therapeutics?

Summary

How does Teladoc Health compare to Roku?

Summary

How does Teladoc Health compare to Zoom Communications?

Summary

How does Teladoc Health compare to American Well?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TDOC vs. The Competition

Teladoc Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Teladoc Health (TDOC) Competitors

TDOC vs. AMZN, CRSP, ROKU, ZM, and AMWL

How does Teladoc Health compare to Amazon.com?

Which has better earnings & valuation, AMZN or TDOC?

Which has more volatility and risk, AMZN or TDOC?

Do analysts rate AMZN or TDOC?

Do insiders & institutionals have more ownership in AMZN or TDOC?

Is AMZN or TDOC more profitable?

Does the media favor AMZN or TDOC?

Summary

How does Teladoc Health compare to CRISPR Therapeutics?

Is TDOC or CRSP more profitable?

Does the media refer more to TDOC or CRSP?

Which has more risk and volatility, TDOC or CRSP?

Which has stronger earnings and valuation, TDOC or CRSP?

Do insiders and institutionals believe in TDOC or CRSP?

Do analysts prefer TDOC or CRSP?

Summary

How does Teladoc Health compare to Roku?

Do analysts recommend TDOC or ROKU?

Do insiders & institutionals hold more shares of TDOC or ROKU?

Which has more risk and volatility, TDOC or ROKU?

Is TDOC or ROKU more profitable?

Does the media prefer TDOC or ROKU?

Which has higher earnings & valuation, TDOC or ROKU?

Summary

How does Teladoc Health compare to Zoom Communications?

Does the media prefer ZM or TDOC?

Is ZM or TDOC more profitable?

Do analysts rate ZM or TDOC?

Do institutionals and insiders hold more shares of ZM or TDOC?

Which has better valuation & earnings, ZM or TDOC?

Which has more volatility & risk, ZM or TDOC?

Summary

How does Teladoc Health compare to American Well?

Does the media prefer AMWL or TDOC?

Which has preferable earnings & valuation, AMWL or TDOC?

Is AMWL or TDOC more profitable?

Which has more volatility and risk, AMWL or TDOC?

Do analysts rate AMWL or TDOC?

Do insiders & institutionals hold more shares of AMWL or TDOC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TDOC vs. The Competition

Teladoc Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools